Cell Lymphoblast Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-12-14
Clinical Trial Update: Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma [Phase 1, Phase 2]
Phase 1 and Phase 2 trial update for ruxolitinib and chidamide in acute T cell lymphoblast leukemia/lymphoblastic lymphoma ongoing; current …